Home / Recalls / Customceutical Compounding / D-1256-2019

D-1256-2019 Class II Terminated

Recalled by Customceutical Compounding — Phoenix, AZ

Recall Details

Product Type
Drugs
Report Date
May 8, 2019
Initiation Date
April 8, 2019
Termination Date
May 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
12 vials

Product Description

HCG (CHORIONIC GONADOTROPIN 1000 IU/ML PEP 25 mg/mL) inj 5 mL multidose vial compounded. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272

Reason for Recall

Lack of assurance of sterility for injectables and solutions intended to be sterile.

Distribution Pattern

U.S.A. Nationwide

Code Information

Lot #: 03132019@23, Exp 5/12/19

Other recalls by Customceutical Compounding

  • D-1261-2019 Class II — Trimix HIGH (Papaverine HCl 30 mg/mL Phentolamine Mesylate 2 mg/mL Alprostadil 2 (April 8, 2019)
  • D-1258-2019 Class II — Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE V (April 8, 2019)
  • D-1253-2019 Class II — BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 25 (April 8, 2019)
  • D-1254-2019 Class II — BPlex (METHYLCOBALAMIN 1000 MCG/ML PYRIDOXAL 5 PHOSPHATE 20MG/ML DEXPANTHENOL 25 (April 8, 2019)
  • D-1255-2019 Class II — Glutathione 200mg/mL inj. a) 10 ML and b) 12 ML MULTIDOSE VIAL MDV Compounded. C (April 8, 2019)
  • D-1260-2019 Class II — Test PROCYP (TESTOSTERONE CYPIONATE 200MG/ML TESTOSTERONE PROPIONATE 20MG/ML), 5 (April 8, 2019)
  • D-1262-2019 Class II — TriMix MEDIUM (Papaverine HCL 21 mg/mL Phentolamine Mesylate 0.7 mg/mL Alprostad (April 8, 2019)
  • D-1259-2019 Class II — Test D (TESTOSTERONE CYPIONATE 200MG/ML VITAMIN D3 5,000IU/ML), 5 ML MULTIDOSE V (April 8, 2019)
  • D-1257-2019 Class II — Lipoplex (METHIONINE 25 MG/ML INOSITOL 50 MG/ML CHOLINE CHLORIDE 50 MG/ML HYDROX (April 8, 2019)